These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31073275)

  • 1. Anti-PD-1 Antibody Administration following Hip Fracture Surgery Reverses Immune Dysfunction and Decreases Susceptibility to Infection.
    Zhang H; Chen C; He J; Zhang J; Liu Z; Sun T
    Mediators Inflamm; 2019; 2019():8492090. PubMed ID: 31073275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
    Guo Z; Wang H; Meng F; Li J; Zhang S
    J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.
    Omori R; Eguchi J; Hiroishi K; Ishii S; Hiraide A; Sakaki M; Doi H; Kajiwara A; Ito T; Kogo M; Imawari M
    Cancer Gene Ther; 2012 Sep; 19(9):637-43. PubMed ID: 22790963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Levingston CA; Young MR
    Int J Cancer; 2017 Apr; 140(7):1609-1619. PubMed ID: 27914100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice.
    Guo X; Xu Y; Luo W; Fang R; Cai L; Wang P; Zhang Y; Wen Z; Xu Y
    BMC Pediatr; 2021 Jul; 21(1):317. PubMed ID: 34271894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
    Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
    Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression.
    Shindo Y; Unsinger J; Burnham CA; Green JM; Hotchkiss RS
    Shock; 2015 Apr; 43(4):334-43. PubMed ID: 25565644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
    Wong M; La Cava A; Singh RP; Hahn BH
    J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.
    Dirks J; Egli A; Sester U; Sester M; Hirsch HH
    Transpl Infect Dis; 2013 Feb; 15(1):79-89. PubMed ID: 23176118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
    Concepcion AR; Salas JT; Sáez E; Sarvide S; Ferrer A; Portu A; Uriarte I; Hervás-Stubbs S; Oude Elferink RP; Prieto J; Medina JF
    Oncotarget; 2015 Oct; 6(30):28588-606. PubMed ID: 26396175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1 blockage delays murine squamous cell carcinoma development.
    Belai EB; de Oliveira CE; Gasparoto TH; Ramos RN; Torres SA; Garlet GP; Cavassani KA; Silva JS; Campanelli AP
    Carcinogenesis; 2014 Feb; 35(2):424-31. PubMed ID: 24031027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced tumor eradication by combining CTLA-4 or PD-1 blockade with CpG therapy.
    Mangsbo SM; Sandin LC; Anger K; Korman AJ; Loskog A; Tötterman TH
    J Immunother; 2010 Apr; 33(3):225-35. PubMed ID: 20445343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis.
    Brahmamdam P; Inoue S; Unsinger J; Chang KC; McDunn JE; Hotchkiss RS
    J Leukoc Biol; 2010 Aug; 88(2):233-40. PubMed ID: 20483923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.
    Teigler JE; Zelinskyy G; Eller MA; Bolton DL; Marovich M; Gordon AD; Alrubayyi A; Alter G; Robb ML; Martin JN; Deeks SG; Michael NL; Dittmer U; Streeck H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.
    Schroder PM; Khattar M; Baum CE; Miyahara Y; Chen W; Vyas R; Muralidharan S; Mierzejewska B; Stepkowski SM
    Diabetologia; 2015 Jun; 58(6):1309-18. PubMed ID: 25794782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with anti-programmed cell death 1 (PD-1) antibody restored postoperative CD8+ T cell dysfunction by surgical stress.
    Sun Z; Mao A; Wang Y; Zhao Y; Chen J; Xu P; Miao C
    Biomed Pharmacother; 2017 May; 89():1235-1241. PubMed ID: 28320090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
    Liu L; Zheng Q; Lee J; Ma Z; Zhu Q; Wang Z
    J Cell Mol Med; 2015 Jun; 19(6):1223-33. PubMed ID: 25810125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Radiotherapy Concurrent with Anti-PD-1 Therapy on the Lung Tissue of Tumor-Bearing Mice.
    Wang F; Luo Y; Tian X; Ma S; Sun Y; You C; Gong Y; Xie C
    Radiat Res; 2019 Mar; 191(3):271-277. PubMed ID: 30694722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.